Literature DB >> 16217705

Phenotypic heterogeneity in two unrelated Danon patients associated with the same LAMP-2 gene mutation.

E Bertini1, M A Donati, P Broda, D Cassandrini, S Petrini, C Dionisi-Vici, L Ballerini, R Boldrini, A D'Amico, E Pasquini, C Minetti, F M Santorelli, C Bruno.   

Abstract

Danon disease, an X-linked cardioskeletal myopathy caused by primary deficiency of lysosome-associated membrane protein-2 (LAMP-2), is clinically characterized by cardiomyopathy, myopathy, and variable mental retardation. The pathological hallmark of the disease is the absence of LAMP-2 immunohistochemical staining in muscle. The LAMP-2 gene mutations reported thus far are generally private mutations. We describe two cases of Danon disease with different clinical presentation, in whom we identified the same exon skipping mutation c.928G>A in the LAMP-2 gene. The first patient was affected by an early onset myopathy and hypertrophic cardiomyopathy (HCM) that partially improved with drug treatment. A first muscle biopsy at age 4 months showed markedly increased glycogen, and acid maltase deficiency was ruled out biochemically. A second muscle biopsy, performed at age 3(1/2) years, showed very mild abnormalities. The second child at age 15 years had mild, diffuse muscle weakness and wasting, moderate mental deficiency, and HCM. Two serial biopsies performed at age 8 and 15 years showed similar findings of multiple esterase-positive vacuoles in type I myofibers. In both patients the immunohistochemical study demonstrated the absence of LAMP-2 in skeletal muscle.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 16217705     DOI: 10.1055/s-2005-872844

Source DB:  PubMed          Journal:  Neuropediatrics        ISSN: 0174-304X            Impact factor:   1.947


  7 in total

1.  LAMP2 microdeletions in patients with Danon disease.

Authors:  Zhao Yang; Birgit H Funke; Linda H Cripe; G Wesley Vick; Debora Mancini-Dinardo; Liana S Peña; Ronald J Kanter; Brenda Wong; Brandy H Westerfield; Jaquelin J Varela; Yuxin Fan; Jeffrey A Towbin; Matteo Vatta
Journal:  Circ Cardiovasc Genet       Date:  2010-02-20

Review 2.  Danon disease - dysregulation of autophagy in a multisystem disorder with cardiomyopathy.

Authors:  Teisha J Rowland; Mary E Sweet; Luisa Mestroni; Matthew R G Taylor
Journal:  J Cell Sci       Date:  2016-05-10       Impact factor: 5.285

3.  Danon disease: intrafamilial phenotypic variability related to a novel LAMP-2 mutation.

Authors:  Sarah-Louise Cottinet; Anne-Marie Bergemer-Fouquet; Annick Toutain; Frédérique Sabourdy; Zoha Maakaroun-Vermesse; Thierry Levade; Alain Chantepie; François Labarthe
Journal:  J Inherit Metab Dis       Date:  2010-12-16       Impact factor: 4.982

Review 4.  Danon disease: clinical features, evaluation, and management.

Authors:  Ryan S D'souza; Cecilia Levandowski; Dobromir Slavov; Sharon L Graw; Larry A Allen; Eric Adler; Luisa Mestroni; Matthew R G Taylor
Journal:  Circ Heart Fail       Date:  2014-09       Impact factor: 8.790

5.  Danon disease: Two patients with atrial fibrillation in a single family and review of the literature.

Authors:  Shaohua Guo; Linghuan Zhou; Renping Wang; Zhixin Lv; Hongzun Xu; Baoli Han; Panagiotis Korantzopoulos; Fuli Hu; Tong Liu
Journal:  Exp Ther Med       Date:  2019-07-17       Impact factor: 2.447

Review 6.  Danon disease: a case report and literature review.

Authors:  Jiamin Xu; Zhu Li; Yihai Liu; Xinlin Zhang; Fengnan Niu; Hongyan Zheng; Lian Wang; Lina Kang; Kun Wang; Biao Xu
Journal:  Diagn Pathol       Date:  2021-05-01       Impact factor: 3.196

7.  Clinical outcome and phenotypic expression in LAMP2 cardiomyopathy.

Authors:  Barry J Maron; William C Roberts; Michael Arad; Tammy S Haas; Paolo Spirito; Gregory B Wright; Adrian K Almquist; Jeanne M Baffa; J Philip Saul; Carolyn Y Ho; Jonathan Seidman; Christine E Seidman
Journal:  JAMA       Date:  2009-03-25       Impact factor: 56.272

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.